Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders

J Biol Regul Homeost Agents. 2019 Mar-Apr,;33(2):609-615.

Abstract

Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broser® is an oral nutraceutical currently containing bromelain 100 mg, escin 30 mg, and selenium 42.5 mcg. It could exert a safe and effective anti-inflammatory activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients.

Keywords: selenium; inflammation; otorhinolaryngology; bromelain; escin.

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Bromelains / therapeutic use*
  • Dietary Supplements
  • Escin / therapeutic use*
  • Humans
  • Inflammation / drug therapy*
  • Otorhinolaryngologic Diseases / drug therapy*
  • Selenium / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Escin
  • Bromelains
  • Selenium